Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth - The Globe and Mail

October 15, 2026The only vendor in the Pace Setters quadrant and the only Asia-based vendor in the report. CyCraft marks its third major international recognition of 2026TAIPEI, TAIWAN – CyCraft Technology (TWSE: 7823), an AI-native cybersecurity company, today announced that it has been positioned in the Pace Setters quadrant of the Gartner Emerging Market Quadrant for AI Application Security, Startup Vendors, published on September 16, 2026. CyCraft Technology is the only vendor in the Pace Setters quadrant and the only Asia-based vendor in the report. XecGuard offers a range of modules that can be tailored to enterprise needs, including General Prompt Attack Protection, System Prompt Enforcement, and Harmful Content Protection. When AI Goes Off-Script, Defense Must Move at Machine Speed Enterprises are handing AI agents real authority: reading email, querying databases, approving transactions, changing system configurations. Attackers are using AI too. They probe AI applications with thousands of prompt variations in minutes, adapt to every refusal, and look for the one input that turns a trusted agent into an insider.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.